Comparison

VSV-G tag Peptide European Partner

Item no. HY-P0328-5mg
Manufacturer MedChem Express
CASRN 103425-05-4
Amount 5 mg
Quantity options 10 mg 1 mg 5 mg
Category
Type Peptides
Specific against other
Purity 99.03
Formula C57H94N16O19S
Citations [1]Liu X, et al. VSV-G Viral Envelope Glycoprotein Prepared from Pichia pastoris Enhances Transfection of DNA into Animal Cells. J Microbiol Biotechnol. 2017 Jun 28;27(6):1098-1105.
Smiles O=C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(O)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCSC)C(N[C@@H](CC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC1=CC=C(C=C1)O)N
ECLASS 5.1 34160400
ECLASS 6.1 34160400
ECLASS 8.0 32160409
ECLASS 9.0 32160409
ECLASS 10.0.1 32160409
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Tyr-Thr-Asp-Ile-Glu-Met-Asn-Arg-Leu-Gly-Lys, YTDIEMNRLGK
Available
Product Description
VSV-G Peptide is a 11 amino acid peptide derived from the Vesicular Stomatitis viral glycoprotein.
StorageTemperature
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Shipping
Blue Ice
Manufacturers Applications
COVID-19-anti-virus
MolecularWeight
1339.52
Clinical_Information
No Development Reported
Manufacturers Research Area
Infection
Solubility
H2O : 2 mg/mL (ultrasonic)
Manufacturers Target
VSV
Pathway
Anti-infection

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close